Modern Healthcare: Congressional Democrats on Thursday introduced a bill to force drugmakers to negotiate prices within Medicare Part D or face losing their patent exclusivity.
Under the proposal, introduced by Rep. Lloyd Doggett (D-Texas) and Sen. Sherrod Brown (D-Ohio), the government could approve a generic competitor if a branded-drug manufacturer doesn't agree to a reasonable Part D price for a given medication. This would give teeth to HHS Secretary Alex Azar's mandate to negotiate prices, but avoids the controversy of excluding certain drugs from coverage under Part D.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now